DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study Meeting Abstract
| Authors: | Doi, T.; Patel, M.; Falchook, G. S.; Koyama, T.; Friedman, C. F.; Piha-Paul, S.; Gutierrez, M. E.; Abdul-Karim, R.; Awad, M.; Adkins, D. R.; Takahashi, S.; Kadowaki, S.; Cheng, B.; Ikeda, N.; Laadem, A.; Yoshizuka, N.; Qian, M.; Dosunmu, O.; Arkenau, H. T.; Johnson, M. L. |
| Abstract Title: | DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S744 |
| End Page: | S745 |
| Language: | English |
| ACCESSION: | WOS:000866211600447 |
| DOI: | 10.1016/j.annonc.2022.07.582 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 453O -- Source: Wos |
